Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Edgewell Personal Care Company (NYSE: EPC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into how Edgewell manages its personal care portfolio, finances and governance, and they are a key resource for anyone analyzing EPC stock.
Investors can review annual reports on Form 10-K for comprehensive discussions of Edgewell’s business, risk factors and performance across its Wet Shave, Sun and Skin Care and Feminine Care segments. Quarterly reports on Form 10-Q update these disclosures with more frequent financial and operational information, including segment results and commentary on market conditions, tariffs and foreign exchange impacts.
Edgewell also files current reports on Form 8-K to describe material events. Recent 8-K filings have covered quarterly and annual earnings releases and the asset purchase agreement to sell the Feminine Care business to Essity, including key terms and closing conditions. These filings help investors track significant strategic decisions, restructuring actions and leadership changes.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) outlines board composition, governance practices, executive compensation programs, shareholder proposals and the agenda for the annual meeting. It also includes management’s discussion of strategy, portfolio transformation and recognition for sustainability and workplace achievements.
On Stock Titan, Edgewell’s filings are supplemented with AI-powered summaries that explain the main points of lengthy documents such as 10-Ks, 10-Qs, 8-Ks and proxy statements in clear language. Real-time updates from EDGAR ensure new filings appear promptly, while specialized views make it easier to locate items such as insider transaction reports on Form 4, stock incentive plan details and other disclosures relevant to EPC shareholders.
Edgewell Personal Care (EPC) reported insider equity activity by its CFO on a Form 4. On 11/13/2025, 2,754 performance stock equivalents were exercised at $0 and converted into common stock, while 958 shares were withheld at $18.39 to cover tax liabilities. Following these transactions, the CFO directly held 27,536 shares of common stock. In a related derivative transaction, the original performance award was 3,900 shares, of which 2,754 vested and 1,146 were cancelled based on performance criteria. On 11/14/2025, the CFO also received 26,476 restricted stock equivalents, scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Edgewell Personal Care Company reported an equity award to one of its officers on Form 4. The reporting person, who serves as President, North America, received 26,476 restricted stock equivalents (RSEs) tied to Edgewell common stock on 11/14/2025 at an exercise price of $0.
According to the vesting terms, one-third of these RSEs will convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, as long as the officer remains employed on those dates. All or a portion of the RSEs may vest earlier upon death, disability, a change in control, or certain termination events.
Edgewell Personal Care Co. (EPC) reported an equity award to its Chief Accounting Officer, John M. Dunham, in a Form 4 filing. On 11/14/2025, he received 3,586 restricted stock equivalents at a price of $0 per unit. These awards are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, converting into shares of Edgewell common stock as they vest. Vesting requires continued employment on each vesting date, although all or a portion may vest earlier in cases such as death, disability, change in control, or certain termination events.
American Century entities filed a Schedule 13G/A reporting beneficial ownership in Edgewell Personal Care (EPC).
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research each report 3,950,190 shares, representing 8.5% of Edgewell’s common stock, with sole voting power 3,808,819 and sole dispositive power 3,950,190 as of 09/30/2025. American Century Capital Portfolios, Inc. reports 2,488,777 shares or 5.4%, with sole voting and dispositive power over the same amount.
The filers certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Edgewell Personal Care Company furnished an update on its business, announcing financial and operating results for its fourth quarter and fiscal year ended September 30, 2025. The results were disclosed via a press release attached as Exhibit 99.1.
The company noted the information was provided under Item 2.02 and is being furnished, not deemed filed under Section 18 of the Exchange Act, and will not be incorporated by reference into other filings except as expressly stated. The press release was issued on November 13, 2025.
Edgewell Personal Care Company (EPC) entered into an Asset Purchase Agreement to sell its Feminine Care segment to Essity for $340 million in cash, subject to customary adjustments for inventory, indebtedness and other items.
Closing is subject to customary conditions, including required approvals under the HSR Act, no legal restraints, accuracy of representations and warranties, and compliance with covenants. Buyer-specific conditions include no material adverse effect on the business, no ongoing substantial destruction of manufacturing facilities, and certain third‑party consents.
The agreement includes customary termination rights if the deal is not completed by May 12, 2026, with automatic extensions to August 12, 2026 and November 12, 2026 if specified regulatory approvals remain outstanding. The Company may receive a $15 million termination fee from the Buyer under certain circumstances tied to regulatory efforts. The parties expect to enter a transition services agreement at closing.
Edgewell Personal Care (EPC) reported insider transactions by its Chief Supply Chain Officer reflecting RSU vesting and tax withholding over three days. On 11/08/2025, 4,425 shares were acquired at $0 via the conversion of restricted stock equivalents, with 2,051 shares withheld for taxes at $18.83. On 11/10/2025, 2,046 shares were acquired at $0 and 949 shares were withheld at $18.83. On 11/11/2025, 1,635 shares were acquired at $0 and 758 shares were withheld at $18.57.
Following these transactions, direct ownership stood at 43,242.693 shares. The filing notes these were conversions of restricted stock equivalents and that shares were withheld to cover tax liabilities upon vesting.
Edgewell Personal Care (EPC): Chief People & Legal Officer LaTanya Langley reported routine equity award activity. Restricted stock equivalents vested and converted into common stock on three dates: 3,688 shares on 11/08/2025, 2,338 shares on 11/10/2025, and 1,635 shares on 11/11/2025, each at an exercise price of $0.
To cover taxes upon vesting, shares were withheld: 1,835 at $18.83 on 11/08/2025, 1,164 at $18.83 on 11/10/2025, and 814 at $18.57 on 11/11/2025. Following these transactions, the officer directly owned 16,767 shares.
Edgewell Personal Care (EPC) reported an insider transaction by its Chief Accounting Officer. On 11/08/2025, 461 shares of common stock were acquired at $0 upon the vesting and conversion of restricted stock equivalents (code M). To cover taxes, 128 shares were withheld at $18.83 (code F).
Following these transactions, the officer directly owns 333 shares of EPC common stock. Derivative holdings consist of 922 restricted stock equivalents after the reported activity.
Edgewell Personal Care (EPC) CEO and director Rod R. Little reported multiple equity transactions. On 11/08/2025, 11/10/2025, and 11/11/2025, restricted stock equivalents vested and converted to common stock (codes M) for 17,285, 14,612, and 12,578 shares at $0, respectively.
To cover taxes on these vestings (code F), shares were withheld: 8,012 at $18.83 on 11/08/2025, 6,773 at $18.83 on 11/10/2025, and 5,830 at $18.57 on 11/11/2025. Following these transactions, Mr. Little beneficially owned 334,373 shares directly.